YiChang HEC ChangJiang Pharmaceutical Company Description

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People’s Republic of China.

It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services.

The company sells its products to hospitals and medical institutions through a network of distributors.

The company’s products are Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It has a strategic cooperation framework agreement with Jointown Pharmaceutical Group Co., Ltd., as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015.

The company was incorporated in 2001 and is based in Yichang, China.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Country	China
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,618
CEO	Juncai Jiang

Contact Details

Address: No. 38, Binjiang Road Yichang China
Website	hec-changjiang.com

Stock Details

Ticker Symbol	1558
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000023R6
SIC Code	2834

Key Executives

Name	Position
Juncai Jiang	GM and Executive Director
Yangui Chen	Head of the Sales Department
Danjin Wang	Deputy GM and Executive Director
Shuang Li	Deputy GM and Executive Director
Hao Chen	Executive Director
Qiang Zhang	Chief Financial Officer and Head of Finance Department
Shengchao Wang	Chief of Quality Division and Employee Representative Supervisor
Qiyun Peng	Joint Company Secretary
Wai Chiu Wong FCS	Joint Company Secretary